Credit Suisse Best Ideas List Still Has 50% Implied Upside for These Stocks24/7 Wall Street • 07/03/19
Why CalAmp, Sarepta Therapeutics, and Motorcar Parts of America Jumped TodayThe Motley Fool • 06/28/19
Gene Therapy Battle: Pfizer's Test Results Sent This Biotech Stock FlyingInvestors Business Daily • 06/28/19
Are Options Traders Betting on a Big Move in Sarepta Therapeutics (SRPT) Stock?Zacks Investment Research • 06/27/19
This Biotech Stock Is Facing A 'Whale' As Pfizer Unveils Gene Therapy DataInvestors Business Daily • 06/24/19
Gene Therapy vs. Gene Editing: Which Is Better for Tackling Muscular Dystrophy?The Motley Fool • 06/09/19
Sarepta Therapeutics (SRPT) Up 2.9% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/07/19
Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/12/19
Sarepta Therapeutics (SRPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseZacks Investment Research • 04/25/19